Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. (Q47783446)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2003

Language	Label	Description	Also known as
English	Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.	scientific article published in August 2003

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

0 references

author name string

Duffy RA

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Hedrick JA

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Randolph G

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Morgan CA

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Cohen-Williams ME

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Vassileva G

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Lachowicz JE

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Laverty M

8

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Maguire M

9

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Shan LS

10

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Gustafson E

11

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Varty GB

12

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

publication date

1 August 2003

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Neuropharmacology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

45

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

242-250

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Pharmacological profile of the novel mammalian tachykinin, hemokinin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Pharmacological profile of hemokinin 1: a novel member of the tachykinin family

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Nonpeptide antagonists of the NK1 tachykinin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Hemokinin 1 is a full agonist at the substance P receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Neurokinin(1) receptor antagonists as potential antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Tachykinin-like peptides and their receptors. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Structure-activity relationship of neurokinin A(4-10) at the human tachykinin NK(2) receptor: the effect of amino acid substitutions on receptor affinity and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Identifiers

10.1016/S0028-3908(03)00150-3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47783446&oldid=1375894114"